Background: Psychosocial risk factors associated with chronic orofacial pain are
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| BACKGROUND
Persistent pain in the face or mouth is a frequent cause for consultation in both primary dental and medical care, and in a substantial proportion of cases, it can become both chronic and disabling (Aggarwal, McBeth, Zakrzewska, Lunt, & Macfarlane, 2008; Macfarlane, Blinkhorn, Davies, Kincey, & Worthington, 2002) . Subjects who report orofacial pain for three months or more report increased pain level and disability and are also more likely to seek treatment and take medication (Macfarlane et al., 2002) . Chronic orofacial pain (OFP) is the characteristic feature of a number of clinical conditions, such as temporomandibular joint disorder (TMD), burning mouth syndrome, atypical odontalgia and atypical facial pain that are difficult to diagnose and treat (Durham, Exley, Wassell, & Steele, 2007; Elrasheed, Worthington, Ariyaratnam, & Duxbury, 2004; Pfaffenrath, Rath, Pöllmann, & Keeser, 1993) . TMD is globally the most common orofacial pain condition, and in the United States, a prevalence of 6% in women and 3.5% in men has been reported (Lipton, Ship, & Larach-Robinson, 1993) ; in the United Kingdom, the prevalence of chronic orofacial pain is similar at 7% (Aggarwal, McBeth, Zakrzewska, Lunt, & Macfarlane, 2006) . The American Academy of Orofacial pain suggests that in any given year 10% of women and 6% of men (approximately 20 million adults) have TMD pain (Gatchel, Stowell, Wildenstein, Riggs, & Ellis, 2006) . Reports from European studies also have similar prevalence figures (6.7%) for TMD (Johansson, Unell, Carlsson, Söderfeldt, & Halling, 2003) .
Patients with chronic orofacial pain are likely to be frequent consulters to primary, secondary and tertiary care and undergo multiple investigations to determine an organic cause for their symptoms-although underlying organic pathology is rarely found (Durham et al., 2007; Elrasheed et al., 2004; Pfaffenrath et al., 1993) . Management of chronic orofacial pain by dentists tends to focus on correction of local mechanical factors, such as teeth grinding and malocclusion. However, evidence in the form of Cochrane systematic reviews has shown little or no beneficial effects of invasive physical therapies such as irreversible occlusal adjustments (Koh & Robinson, 2003) and oral splints (Al-Ani, Gray, Davies, Sloan, & Glenny, 2005; List & Axelsson, 2010) . Indeed, an audit of 101 consecutive referrals of persistent orofacial pain to a secondary care Oral Surgery department (Beecroft, Durham, & Thomson, 2013) showed that patients had been treated in nine different hospitals, referred to 15 distinct specialties with a mean of seven consultations per specialty. Overall 341 treatment attempts had been made and only 24% yielded a successful outcome. The study concluded that there was a need for evidence-based management and specialist regional centres (Beecroft et al., 2013) .
Patients with orofacial symptoms also frequently consult their general medical practitioner (69%) rather than general dental practitioners (31%) (Bell, Smith, Rodgers, Flynn, & Malone, 2008) . General medical practitioners do not have the infrastructure or knowledge to manage chronic orofacial pain and indeed find it difficult (Peters et al., 2015) . Patients are therefore referred from specialist to specialist and have multiple tests, investigations and often invasive and irreversible treatments that do not improve symptoms (Beecroft et al., 2013; Durham et al., 2007; Elrasheed et al., 2004; Pfaffenrath et al., 1993) . Costs of TMD alone in the United States are in the region of $4 billion annually (Gatchel et al., 2006) , and a study examining the costs to the UK National Health Service (Durham, Shen et al., 2016) showed that consultation costs were a significant proportion (p < 0.001) of cumulative healthcare utilization costs of patients with persistent orofacial pain. This imposes a huge burden on already stretched healthcare resources. The descriptive epidemiology of chronic orofacial shows a strong association with psychosocial risk factors (Aggarwal et al., 2008; Bair et al., 2016; Slade et al., 2007 Slade et al., , 2016 ) and a co-occurrence with other long-term conditions like chronic widespread pain (CWP), irritable bowel syndrome (IBS) and chronic fatigue (CF) (Aggarwal et al., 2006; Bair et al., 2016; Slade et al., 2016) .
In line with a global drive to curb the epidemic of noncommunicable diseases and long-term conditions, UK government policy places an emphasis on using self-management to improve management of long-term conditions through patient participation and ownership of their own health care (Department of Health, 2001 . Self-management approaches (where the person takes an active role in managing their condition rather than a passive one that is more dependent on others) are increasingly accepted for chronic pain (Nicholas & Blyth, 2016) . This term refers to all actions taken by individuals to manage the symptoms, treatment, physical and psychosocial consequences and lifestyle changes inherent in living with a chronic condition (Barlow, Wright, Sheasby, Turner, & Hainsworth, 2002) . Self-management interventions aim to increase the capacity, confidence and efficacy of the individual and are increasingly viewed as core strategies of the management of chronic conditions (Kennedy et al., 2013) . Education and skill development are two common components of those interventions that are tailored to influence individual's cognitive, behavioural and emotional responses to maintain and strengthen a satisfactory quality of life (Barlow, 2001) . The boundary between "active" and "passive" treatment however is not absolute, and it could be argued that anything done by the patient in an endeavour to better manage their symptoms, function or associated distress could be viewed as self-management. However, the term self-management approach normally has a specific cognitive or behavioural focus and is normally contrasted with passive treatment primarily delivered by a healthcare practitioner. Currently, it is normally taken to apply to pain coping strategies employed by the patient to help manage their pain and its impact. This aligns with TMD interventions which aim to target these factors using techniques such as psychoeducation, relaxation, jaw posture control, cognitive behaviour therapy (CBT) and biofeedback as per previous studies Litt, Shafer, Ibanez, & Kreutzer, 2009; Turner, Holtzman, & Mancl, 2007; Turner, Whitney, Dworkin, Massoth, & Wilson, 1995) . These studies have not only outlined components for biopsychosocial interventions for chronic orofacial pain and TMD but also explored the mechanisms by which self-care interventions involving both psychosocial self-care and jaw posture control can bring about change in patients with chronic orofacial pain. Guided self-care interventions can target vicious cycles associated with both fear-avoidance behaviour (central pain processing mechanisms) and "anxiety-pain-tension" cycles involving muscle over activity linked to emotional stress (depression, anger, fears and anxieties about the pain), which in turn may increase pain by precipitating activity in psychophysiological systems. By changing patient beliefs and developing coping strategies, self-management interventions have the potential to induce a return to normal functioning. Litt et al., 2009; Turner et al., 2007 Turner et al., , 1995 . Such interventions are noninvasive and have the potential, if effective, to be applied across health care and delivered by general medical practitioners to whom patients with orofacial symptoms frequently consult.
Key components of such interventions have included psychoeducation, relaxation, CBT and biofeedback Litt et al., 2009; Turner et al., 2007 Turner et al., , 1995 . However, biofeedback, in particular EMG biofeedback (Gatchel et al., 2006) , requires not only expensive equipment but also time spent on training and particularly time spent by patients on practice. This may not be amenable to self-management particularly for interventions that need to be delivered remotely by telephone or Web-based interactions.
The aim of the current review was therefore to assess the effectiveness of self-management interventions compared with usual care in the management of adults with chronic orofacial pain.
Specific objectives:
1. To determine whether, in adults with chronic orofacial pain including temporomandibular disorders (TMD), self-management interventions more effective than usual care in improving long-term outcomes related to pain intensity and psychosocial well-being. 2. To determine whether the biofeedback component of interventions shows an additional treatment effect compared to no biofeedback. 3. To determine the effectiveness of self-management for subtypes of chronic orofacial pain in particular TMD which is the most common subtype.
| METHODS
This systematic review and meta-analysis were undertaken following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement Moher, Liberati, Tetzlaff, Altman, & PRISMA Group, 2009 ). This study is registered with PROSPERO (CRD42017060158; Aggarwal, Fu, Main, & Wu, 2018 
| Types of participants
Adults over 18 years of age with chronic orofacial pain defined as those diagnosed with the following conditions: temporomandibular disorders (TMD), atypical facial pain, atypical odontalgia and burning mouth syndrome. Other terms used to describe these conditions were also included in the search strategy, for example, myofacial pain, myofascial pain related to the facial region, craniomandibular/ oromandibular dysfunction, mandibular stress syndrome, facial arthromyalgia, masticatory muscle disorder, masticatory myalgia, TMJ syndrome, stomatodynia, persistent idiopathic facial pain and persistent dento-alveolar pain. 
| Types of outcome measures

| Types of interventions
Self-management interventions were defined as those that included patient participation in the intervention. work as part of the intervention protocol. Other components were education, psychological such as cognitive behaviour therapy or its components (cognitive therapy, behavioural therapy) and physical self-regulation, for example, posture control, habit reversal, relaxation and/or biofeedback. Table 1 summarizes the intervention components of studies and how these map onto self-management.
| Search methods for identification of studies
For the identification of studies included or considered for this review, detailed search strategies were developed for each database searched. These were based on the search strategy developed for MEDLINE (OVID) but revised appropriately for each database.
The following electronic databases were searched (to 29 September 2017): The Cochrane Oral Health Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE via OVID, EMBASE via OVID, PsycINFO via OVID, WHO International Clinical Trials Registry Platform, and Clinical Trials.gov. There were no restrictions regarding language or date of publication. The search strategy used a combination of controlled vocabulary and free text terms for identifying randomized trials (RCTs) in MEDLINE. Details of the search strategy are provided in Supporting Information Appendix S1.
The reference lists of all eligible trials were checked for additional studies. Where these had not already been searched, the journals were hand searched by the review authors if electronic copies were not available.
| Data collection and analysis
| Selection of studies
The title and abstracts of relevant articles and reports from the search strategy outlined in Supporting Information Appendix S1 were screened independently by two review authors (VA and JW). Full reports were obtained where trials met the inclusion criteria or where a clear decision could not be made from the title or abstract. Disagreements were resolved by discussion, and full reports of all studies potentially meeting the inclusion criteria were obtained. Full reports were used to assess trials where inclusion was unclear and reasons for rejection were clear upon examining full reports. Main reasons for rejection were as follows: Studies were not randomized controlled trials and had the wrong disease definition and/or patient group.
| Data extraction and management
Data were extracted, independently and in duplicate, using a previously prepared data extraction form which included the characteristics of trial participants, interventions, control groups and outcomes. Characteristics of included studies are presented in Supporting Information Appendix S2. VA extracted all the studies while JW and YF shared equally extraction for the purpose of duplication. Any differences were resolved by discussion. Differences involving risk of bias were resolved by using the most frequent option selected, for example, if two of the three reviewers were in agreement then we chose that option. There were no instances where there was disagreement between all 3 reviewers. Prior to extraction, the data extraction form was piloted using three studies and all authors extracting the data participated in the piloting so that they were clear about the extraction process. The data extraction form was modified for ease of use following the pilot extractions.
| Assessment of risk of bias in included studies
The assessment of risk of bias in the included trials was undertaken independently and in duplicate as part of the data extraction process by three of the review authors (VA, JW and YF) as described above and in accordance with the Cochrane Handbook for Systematic Reviews of Interventions 5.0.2 (Higgins & Green, 2011) . Included trials were assessed on the following criteria:
• adequate sequence generation • concealed allocation of treatment • blinding of participants/caregivers (where feasible) and outcome assessors • incomplete outcome data • selective outcome reporting • any other bias relevant to the study A description of the quality items was tabulated for each included trial, along with a judgement of low, high or uncertain risk of bias. Criteria for risk of bias judgements regarding allocation concealment were as described in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins & Green, 2011): • Low risk of bias-adequate concealment of the allocation (e.g., sequentially numbered, sealed, opaque envelopes or centralized or pharmacy-controlled randomization).
• Uncertain risk of bias-uncertainty about whether the allocation was adequately concealed (e.g., where the method of concealment is not described or not described in sufficient detail to allow a definite judgement).
• High risk of bias-inadequate allocation concealment (e.g., open random number lists or quasi-randomization such as alternate days, date of birth or case record number).
A summary assessment of the risk of bias for the primary outcome (across domains) within and across studies was undertaken. Within a study, a summary assessment of low risk of bias was given when there was a low risk of bias for all key domains, unclear risk of bias when there was an unclear risk of bias for one or more key domains, and high risk of bias when there was a high risk of bias for one or more key domains. Across studies, a summary assessment was rated as low risk of bias when most information is from studies at low risk of bias, unclear risk of bias when most information was from studies at low or unclear risk of bias, and high risk of bias when the proportion of information was from studies at high risk of bias sufficient to affect the interpretation of the results.
| Measures of treatment effect
For dichotomous outcomes, treatment effects were expressed as risk ratios with 95% confidence intervals while for continuous outcomes mean differences with 95% confidence intervals were used. All analyses were performed using R version 3.4.1 (https://cran.r-project.org/; R Core Team, 2013).
| Assessment of heterogeneity
Clinical heterogeneity was accounted for by inclusion criteria for uniform disease definition, assessing components of the interventions and outcome measures included in the trials. Statistical heterogeneity was assessed by means of Cochrane Q, where a large Q value indicates the presence of heterogeneity, and the I 2 statistic where I 2 gives the percentage of variability in the effect estimate that is due to heterogeneity rather than to chance. Suggested thresholds for the interpretation of I 2 are as follows: Less than 40% indicate there is no problem with heterogeneity, 30%-60% indicates a moderate problem, 60%-90% a substantial problem and 75% and over considerable heterogeneity (Higgins & Green, 2011 ).
| Assessment of reporting biases
Reporting biases were assessed through funnel plots for outcomes that were reported by more than five studies. Egger's test was used to test the statistical significance of reporting biases for each outcome.
| Data synthesis
Meta-analyses were only carried out if trials were of similar comparisons reporting the same outcome measures. Estimates of effect were combined using a random-effects model. Mean differences or standardized mean differences were used for the same outcomes with different scales.
| Quality of evidence
We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to assess the quality and certainty of the body of evidence per outcome, in accordance with the Cochrane Handbook for Systematic Reviews of Interventions 5.0.2 (Higgins & Green, 2011) . For the most important outcomes, we used the programme GRADE pro GDT 2015 to generate a certainty of evidence table (Table 2 ). Starting from an assumed level of high quality, this reduced the quality of the evidence by one or more levels if there were one or more limitations in the risk of bias, consistency, and/or precision of the pooled estimate. The level of evidence as then rated as either high, moderate, low or very low depending on the number of limitations.
| Assessment of intervention components
| Meta-regression
Simple mixed-effects meta-regression was used to investigate whether biofeedback provided additional treatment effect. We performed meta-regression on outcome measures of long-term pain and depression between patients with biofeedback and those without biofeedback.
| RESULTS
| Description of studies
A detailed description of the studies is in the characteristics of included and excluded studies presented in Supporting Information Appendix S2.
| Results of the search
The initial search strategy yielded 1,104 references which were assessed blind and independently by VA and JW, and based on the abstracts and titles, these were reduced to 48 relevant manuscripts (Figure 1 ). Main reasons for exclusion were that a large proportion of studies were not trials and others were not on chronic orofacial pain. All the 48 manuscripts identified above were extracted by the lead author VA. Extraction was duplicated by sharing blind and independently between the other co-authors (JW, YF). Sixteen manuscripts were relevant for analysis and are presented in the characteristics of included studies table in Supporting Information Appendix S1. A number of trials that were duplicates of the same study were merged. Reasons for exclusion at this stage were interventions not compatible with self-management, had the wrong disease definition and/or patient group, and they were not randomized controlled trials. Of the 16 studies which met all eligibility criteria and hence included in this review, Dworkin's 2 studies ) and Komiyama's study (Komiyama, Kawara, Arai, Asano, & Kobayashi, 1999) displayed results graphically and we did not have means and standard deviations to pool these studies. Authors were The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
contacted to obtain data but only provided means and no standard deviations or did not respond. This left 14 studies for inclusion in the final meta-analysis (Figure 1 ).
| Included studies
All of the included trials had comparable control groups comprising usual treatment which involved conservative treatment composed of education, counselling and an intraoral flat-plane appliance. The Bergdahl study (Bergdahl, Anneroth, & Ferris, 1995) included a control group of attention placebo and the Townsend study (Townsend, Nicholson, Buenaver, Bush, & Gramling, 2001 ) included a waiting list control with no intervention and were therefore not pooled in the meta-analysis as they had different comparators. They were however used for the GRADE analysis ( Table 2) . The interventions for self-management were as defined previously. Outcome measures included short-term (3 months or less) and long-term (more than 3 months) pain intensity and long-term measures for muscle palpation pain, activity interference and depression.
| Risk of bias in included studies
Risk-of-bias plots are displayed in Figure 2a ,b, the former showing the overall risk of bias and the latter individual plots for each study. Figure 2c shows funnel plots for publication bias.
| Blinding (performance bias and detection bias)
It is notable that due to the nature of the intervention, blinding was difficult where the intervention and controls were concerned. However, it was possible for outcome assessment, and for the purposes of this review, we evaluated whether included studies had blinded outcome measurement. This was reported by seven of the included studies (Carlson, Bertrand, Ehrlich, Maxwell, & Burton, 2001; Dworkin et al., 1994; Ferrando et al., 2012; Gardea, Gatchel, & Mishra, 2001; Goldthorpe et al., 2017; Shedden-Mora, Weber, Neff, & Rief, 2013; Turner, Mancl, & Aaron, 2006) , and three did not report at all (Bergdahl et al., 1995; Gatchel et al., 2006; Litt, Shafer, & Kreutzer, 2010) . The remaining studies were unclear (Figure 2b ). The overall risk of bias was deemed low in this area (Figure 2a ).
| Incomplete outcome data (attrition bias)
Only three trials did not report on incomplete outcome data; nine fully reported this (Bergdahl et al., 1995; Carlson et al., 2001; Dworkin et al., 1994; Ferrando et al., 2012; Gardea et al., 2001; Gatchel et al., 2006; Goldthorpe et al., 2017; Shedden-Mora et al., 2013; Turner et al., 2006) , and the one was unclear (Litt et al., 2010) and risk of bias ( Figure 2b ) was therefore low for this domain (Figure 2a ).
| Allocation (selection bias)
This was not reported by only three of the included studies (Ferrando et al., 2012; Litt et al., 2010) ; fully reported by four studies (Gardea et al., 2001; Goldthorpe et al., 2017; Shedden-Mora et al., 2013; Turner et al., 2006) ; and the remaining studies were unclear (Figure 2b) . Overall, the risk of bias in this area was therefore low (Figure 2a ).
| Selective reporting (reporting bias)
None of the included trials had selective reporting and therefore were assessed as being at low risk of bias for selective reporting (Figure 2a ).
| Publication bias
There were only two outliers for short-term pain intensity and one for long-term pain intensity and activity interference for funnel plots (Figure 2c ) which may indicate the existence of publication bias. However, formal tests showed that this was not statistically significant (Egger's test, p-value for shortterm pain = 0.35, long-term pain = 0.52, activity interference = 0.34 and long-term depression = 0.69). 1986; Dworkin et al., 1994; Ferrando et al., 2012; Gardea et al., 2001; Goldthorpe et al., 2017; Litt et al., 2010; SheddenMora et al., 2013; Turk, Zaki, & Rudy, 1993) . Due to substantial heterogeneity (I 2 = 62%), the results of these studies could not be pooled (Figure 3) . Hence, no overall conclusions could be drawn for this domain. Of the studies that did not have quantitative data for this outcome, the Komiyama paper (Komiyama et al., 1999) showed no differences in pain intensity between the self-management intervention and control groups. In contrast, the Dworkin comprehensive care programme study showed significant improvement in short-term pain intensities between self-management and usual care.
| Self-management interventions versus usual care-pain (long term)
Nine studies provided data on this outcome (Carlson et al., 2001; Dworkin et al., 1994; Gardea et al., 2001; Gatchel et al., 2006; Goldthorpe et al., 2017; Litt et al., 2010; SheddenMora et al., 2013; Turk et al., 1993; Turner et al., 2006) . Due to low heterogeneity (I 2 = 7%), the results of the studies could be pooled for the purpose of statistical analysis (Figure 4 ). This showed a statistically significant difference in favour of self-management interventions (SMD −0.32, 95% CI −0.47 to −0.17), and this represented a 16% improvement in long-term pain for self-care versus usual care for patients with chronic orofacial pain (Figure 4 ). Considering subgroups of interventions, statistically significant differences were observed for self-care CBT (SMD −0.26, 95% CI −0.45 to −0.07) and combined biofeedback and CBT (SMD −0.46 95% CI −0.72 to −0.20) (Figure 4) . Of the studies that did not have quantitative data for this outcome, the Dworkin self-care intervention showed significant (p < 0.05) improvement in long-term pain intensity while the comprehensive care programme study did not.
| Self-management interventions versus usual care-muscle palpation pain (long term)
Overall only three studies provided data on this outcome (Carlson et al., 2001; Turk, Rudy, Kubinski, Zaki, & Greco, 1996; Turk et al., 1993) .
Only three studies provided data on this outcome, and because there was substantial heterogeneity (I = 63%), the pooled results were unreliable although they showed a significant improvement in muscle palpation pain (SMD −0.58 95% CI −0.92 to −0.24) ( Table 3 ). There were insufficient data to draw any conclusions regarding any of the individual interventions with regard to muscle palpation pain (long term). Of the studies that did not have quantitative data for this outcome, the Dworkin self-care intervention showed significant (p < 0.05) improvement in this outcome.
| Self-management interventions versus usual care-activity interference (long term)
A total of eight studies provided data for this outcome (Carlson et al., 2001; Dworkin et al., 1994; Ferrando et al., 2012; Gardea et al., 2001; Goldthorpe et al., 2017; Litt et al., 2010; Shedden-Mora et al., 2013; Turk et al., 1996) .
Eight studies provided data for this outcome, and there was a significant effect of the pooled results (SMD −0.29 95% CI −0.47, −0.11) (Table 3 ). However, because there was substantial heterogeneity (I 2 = 79%) the pooled results are unreliable. Individually, there was statistically significant difference for self-care CBT (SMD −0.37 95% CI −0.57, −0.16). Of the studies that did not have quantitative data for this outcome, the Dworkin self-care intervention showed significant (p < 0.05) improvement in this outcome while the comprehensive care programme study did not.
| Self-management interventions versus usual care-depression (long term)
A total of seven studies provided data for the statistical analysis for this outcome (Carlson et al., 2001; Gatchel et al., 2006; Goldthorpe et al., 2017; Litt et al., 2010; Shedden-Mora et al., 2013; Turk et al., 1996 Turk et al., , 1993 . Overall seven studies provided data on this outcome and there were statistically significant differences in favour of psychosocial interventions (SMD −0.32, 95% CI −0.50 to −0.15) ( Figure 5 ) and this represented a 25% improvement in long-term pain for psychosocial interventions versus usual care. There was no heterogeneity (I 2 = 0%; Figure 5 ).
Individually, both self-care CBT and CBT/biofeedback show statistically significant benefit over usual care with regard to depression (SMD −0.27, 95% CI −0.49 to −0.05)
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Comparison-any self-management intervention versus usual care outcome-pain short term (3 months or less) and (SMD −0.41, 95% CI −0.68 to −0.13) respectively ( Figure 5 ).
| Certainty of the evidence
The certainty of the evidence was high for the main outcome measures as assessed using GRADE criteria (Table 2) . For the key outcome measures of long-term pain intensity and depression, there were 757 participants (12 RCTs) and 524 participants (8 RCTs), respectively.
For other outcome measures that were not pooled, the quality of evidence was also high and significant effects were observed for the effects of self-management interventions on activity interference (SMD −0.29, 95% CI −0.47 to −0.11) and long-term muscle palpation pain (SMD −0.58, 95% CI −0.92 to −0.24). The effect for short-term pain remained nonsignificant (SMD −0.06, 95% CI −0.21 to 0.09).
| Subgroup analysis
A subgroup analysis for trials that only included TMD studies showed similar significant effects on long-term pain and depression SMD −0.34 (−0.50, −0.19) and −0.33 (−0.51, −0.15), and results could be pooled due to low heterogeneity (Table 4) . 
| Components of self-management
Meta-regression was conducted to test whether biofeedback component showed an additional treatment effect compared with no biofeedback. The outcomes of long-term pain and depression were used to assess this effect. Of the 11 studies reporting long-term pain, five studies also used biofeedback in the intervention. The coefficient estimate from meta-regression for using biofeedback was (−0.16, 95% CI −0.48 to 0.17, p-value = 0.360). Of the eight studies reporting longterm depression, three studies also used biofeedback in the intervention. The coefficient estimate from meta-regression for using biofeedback was (−0.13, 95% CI −0.50 to 0.23, p-value = 0.475).
| DISCUSSION
| Summary of main results
This systematic review has shown for the first time that there is strong evidence to support the use of self-management interventions to improve long-term outcomes for patients with chronic orofacial pain and TMD. There were significant effects for improvement in long-term pain and depression, the studies were at low risk of bias, and there were sufficient numbers of studies that could be pooled to give an overall treatment effect. The quality and certainty of evidence for the main outcome measures (pain and depression) were high using GRADE scores. For other outcome measures, the quality of evidence was also high in GRADE despite the heterogeneity observed for these outcomes in the meta-analysis. Self-management interventions therefore also showed significant improvement on activity interference and long-term muscle palpation pain. The descriptive analysis of studies and interventions used showed that all but two of the included studies were on TMD and that self-management interventions for chronic orofacial pain (mainly TMD) include education, physical (jaw posture relaxation) and psychosocial (cognitive, behavioural) self-regulation. Meta-regression showed that biofeedback did not provide additional contribution to effect size. Given that some types of biofeedback, such as masseter EMG biofeedback, require additional expensive equipment, training and particularly time for patients to practise, further evaluation is required on the value of biofeedback in self-management of chronic orofacial pain.
| Implications for management of chronic orofacial pain
Overall, the components identified by the review map onto a biopsychosocial intervention model involving both physical and psychological approaches to the management of chronic orofacial pain (mainly TMD). This is not dissimilar to approaches identified for management of chronic back pain (with which TMD co-occurs) and which have been shown to be cost-effective (Hill et al., 2011 (Hill et al., , 2013 Main, Sowden, Hill, Watson, & Hay, 2012) .
Physical self-regulation and education as active components for TMD self-management are supported by a Delphi study. It showed that main components of a standard selfcare programme of TMD were agreed to comprise education; self-exercise; self-massage; thermal therapy; dietary advice and nutrition; and parafunctional behaviour (Durham, Al-Baghdadi et al., 2016) . However, it did not include psychological components which were shown to be integral in the management of TMD in our current systematic review. Previous studies using a predominantly psychosocial approach (Goldthorpe et al., 2017) identified the need for physical self-regulation as an additional component. It was not included in their patient manual, but recognized as an important component for management of patients in their trial.
Indeed, current recommendations for TMD management (The European Pain Federation ) state that physiotherapy and pain management psychology can be useful. This is in agreement with the descriptive components of self-management interventions identified in our review that show packages of both physical and psychosocial components appear beneficial. Future research needs to explore how these approaches interact separately and/or combined in a single intervention. Indeed, this can have implications for pain management programmes including those for orofacial pain which tend to address physical and psychosocial management separately, for example, by referral to a physiotherapist and/or clinical psychologist. It may be that such interventions delivered as a package by skilled clinicians using a biopsychosocial approach may be more appropriate. Indeed, it has been found to be effective for physiotherapists to deliver a self-management package (comprising education, physical and psychosocial components) for biopsychosocial management of back pain (Hill et al., 2011 (Hill et al., , 2013 Main et al., 2012) . Both future trials and current pain management programmes for chronic orofacial pain and TMD should prioritize a biopsychosocial approach that includes education, physical and psychosocial components. Indeed, self-reports of jaw parafunction, psychosocial factors and reporting of other somatic symptoms have been shown to be the strongest predictors of TMD the large prospective OPERRA study (Slade et al., 2007 . These risk factors lend themselves to the biopsychosocial approach identified by the findings of the current systematic review.
It is important to note that the trials included in the current review were mainly on TMD. The physical self-regulation (jaw posture relaxation) component is therefore relevant to TMD alone rather than all facial pain subtypes as TMD is commonly associated with parafunctional habits (Durham, Al-Baghdadi et al., 2016) . Future research needs to explore the effects of self-management on all facial pain subtypes as per the study by Goldthorpe et al., (2017) and determine whether physical self-regulation components are effective for other subtypes of chronic orofacial pain.
| Implications for future research
The studies eligible for inclusion in this review were conducted in secondary care where patients had developed longstanding chronic orofacial pain. Given the effectiveness of self-management in this group of patients, future studies need to be conducted in primary care to explore whether early intervention can improve outcome by preventing chronicity. This certainly appears to be the case for early intervention in tertiary care (Gatchel et al., 2006) . Future trials also need to standardize outcome measures so that they can be comparable across trials. In the current review, we were able to compare effectiveness for pain intensity and physical and emotional functioning using outcomes available in the included trials. Of these, only outcomes for pain intensity and emotional functioning (depression was the only outcome across trials that was measured) could be pooled in the meta-analysis. Physical functioning represented by activity interference could not be pooled due to high heterogeneity. Outcome measures for these domains (pain intensity, physical and emotional functioning) need to be standardized for future trials so that results can be compared across trials and pooled for meta-analyses. Core outcome measures for chronic pain in clinical trials have been clearly defined by initiatives such as IMMPACT, and these would appear to be an appropriate benchmark (Turk et al., 2008) for future trials on chronic orofacial pain and TMD. Indeed, there are several dimensions of emotional functioning like fear of pain, catastrophizing and anxiety that are relevant to pain management but due to the lack of homogeneity in their measurement we were unable to assess their effects. Future work that explores the mechanisms by which these interventions bring about change is also needed to inform outcome measures. For example, Turner et al. (2007) examined potential mediators, moderators and predictors of patient improvement with CBT. It was a novel study that examined whether pre-to post-treatment process variable changes mediated CBT effects on subsequent outcomes (Turner et al., 2007) . The results showed that changes in perceived pain control and self-efficacy were important in explaining the treatment effects of CBT on the outcomes and should be considered in designing future behavioural interventions for TMD. A further study by Litt et al. (2010) also showed that somatization, self-efficacy and readiness for treatment were significant moderators. Work by our group assessed processes of engagement with a self-management intervention, and this showed that key mechanisms of change centred around: identification with the intervention; feeling believed and understood; obtaining a plausible explanation for symptoms; degree of perceived effort required to engage; acceptance of having a long-term condition; and receiving demonstrative, positive feedback . These studies indicate that self-efficacy, pain control, and understanding and accepting the chronicity of the conditions are important biopsychosocial predictors of patient improvement and should be incorporated into future interventions. This is similar to other chronic pain conditions like chronic back pain whereby mediators like obtaining a plausible explanation for symptoms and knowledge of the condition have led to the development of public health approaches (Roland, Waddell, Klaber Moffett, Burton, & Main, 2002; Waddell, Moffett, & Burton, 2004; Williams et al., 2009) . Such approaches need to be considered for chronic orofacial pain and TMD, and indeed, specific self-management advice can be included in both primary care dental and medical practices. Over-the-counter pain relief such as nonsteroidal anti-inflammatory drugs are particularly useful for TMD pain and can be incorporated into self-management plans. This will avoid the need for costly invasive and irreversible procedures like surgery, occlusal rehabilitation and splints.
| Quality of the evidence in the review and comparison to previous reviews
The risk of bias pertaining to each item discussed in the results section was low for the majority of domains used in the assessment. The GRADE scoring showed that the certainty of evidence was high for all the outcome measures. Therefore, the quality of the evidence was high for trials included in the review. The component analysis showed that all trials included self-management and physical and psychosocial self-regulation. Only six studies included biofeedback for which we were able to conduct a meta-regression. This showed that biofeedback alone does not produce an effect in the meta-regression model with very low residual heterogeneity (I 2 = 7%).
The results of the current review update the findings of our previous Cochrane systematic review (Aggarwal et al., 2011) , which showed that psychosocial interventions were effective in improving long-term outcomes for patients with chronic orofacial pain. However, that review failed to acknowledge the importance of the components within the interventions and grouped all interventions into a psychosocial group. In addition, the evidence was weak as few studies were included and an overall quality assessment of the quality of evidence was not conducted. Other systematic reviews in this area (Liu et al., 2012; Randhawa et al., 2016) have suffered from methodological shortcomings due to the limited amount of studies, lack of meta-analysis and including interventions with a number of disparate components all of which have led to inconclusive findings.
| Potential biases
Given that the majority of interventions were delivered by a therapist, bias arising from therapeutic alliance related to the quality of doctor-patient relationship may be present which can drive nonspecific effects (placebo effect in clinical practice and Hawthorne effect in clinical studies). Further, included studies were conducted in tertiary care settings which specialized in the management of chronic orofacial pain. This may affect the generalizability of the results as patients in these settings are likely to represent the more severe and intractable cases of chronic orofacial pain and hence share common characteristics. Future trials need to explore early management of chronic orofacial pain in primary care using these interventions. While we concluded that overall risk of bias was low and indeed trials by Turner et al., (2006) and Shedden-Mora et al., (2013) were completely free of the domains of bias assessed, data permitting, we would have used sensitivity analyses to examine the effect of concealed allocation, intention-to-treat analysis and blind outcome assessment on the overall estimates of effect.
| CONCLUSIONS
The findings of this review provide strong evidence for the use of noninvasive self-management interventions for patients with chronic orofacial pain (mainly TMD). The components of these interventions included physical selfregulation (jaw posture regulation), psychosocial (cognitive and behavioural) self-regulation and education. Future work needs to prioritize the use of these interventions in early management of chronic orofacial pain including TMD.
